Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Renal Failure

  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 116 articles:
HTML format

Single Articles

    December 2021
  1. NODA R, Kamano D, Abe T, Shinzawa S, et al
    Granuloma formation after peritoneal dialysis catheter-related infection by Mycobacterium chelonae.
    Kidney Int. 2021;100:1355.

  2. LOPEZ T, Banerjee D
    Management of fluid overload in hemodialysis patients.
    Kidney Int. 2021;100:1170-1173.
    PubMed     Abstract available

  3. EL-HUSSEINI A, Sobh M, Elshabrawy N, Abdalbary M, et al
    Antiresorptives in patients with chronic kidney disease with adynamic bone: Is absence of evidence of harm equal to no harm?
    Kidney Int. 2021;100:1341-1342.

  4. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    PubMed     Abstract available

    November 2021
  5. KAESLER N, Schreibing F, Speer T, Puente-Secades S, et al
    Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease.
    Kidney Int. 2021 Nov 10. pii: S0085-2538(21)01056.
    PubMed     Abstract available

  6. OGATA S, Akashi Y, Sakusabe T, Yoshizaki S, et al
    A multiple 24-hour urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease.
    Kidney Int. 2021 Nov 10. pii: S0085-2538(21)01057.
    PubMed     Abstract available

  7. JANKOWSKI V, Saritas T, Kjolby M, Hermann J, et al
    Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease.
    Kidney Int. 2021 Nov 9. pii: S0085-2538(21)01034.
    PubMed     Abstract available

    Role of FGF23 in clinical outcomes of patients with chronic kidney disease.
    Kidney Int. 2021;100:993-994.

    Telomere length and chronic kidney disease: cause or consequence?
    Kidney Int. 2021;100:980-983.
    PubMed     Abstract available

  10. ROSEN RJ, Fernandez HE, Shirazian S, Moses AA, et al
    Ultrasound findings of calciphylaxis.
    Kidney Int. 2021;100:1144.

    October 2021
  11. TERKER AS, Ikizler TA
    Untangling the fibers of sarcopenia: activin A in chronic kidney disease-associated muscle wasting.
    Kidney Int. 2021 Oct 27. pii: S0085-2538(21)01022.

  12. DAVIDOVIC T, Schimpf J, Abbassi-Nik A, Stockinger R, et al
    Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost.
    Kidney Int. 2021 Oct 14. pii: S0085-2538(21)00942.

  13. PONTE B, Sadler MC, Olinger E, Vollenweider P, et al
    Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease.
    Kidney Int. 2021 Oct 8. pii: S0085-2538(21)00922.
    PubMed     Abstract available

  14. STERVBO U, Blazquez-Navarro A, Blanco EV, Safi L, et al
    Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00925.

  15. OLAOYE OA, Koratala A
    Autogenous brachial-axillary translocated superficial femoral vein hemodialysis access with a prosthetic outflow bypass.
    Kidney Int. 2021;100:951.

    September 2021
  16. EIKELBOOM J, Floege J, Thadhani R, Weitz JI, et al
    Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target.
    Kidney Int. 2021 Sep 30. pii: S0085-2538(21)00870.
    PubMed     Abstract available

  17. HEERSPINK HJ, Cherney D, Postmus D, Stefansson BV, et al
    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
    Kidney Int. 2021 Sep 21. pii: S0085-2538(21)00865.
    PubMed     Abstract available

  18. BISSINGER R, Nemkov T, D Alessandro A, Grau M, et al
    Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Kidney Int. 2021 Sep 16. pii: S0085-2538(21)00858.
    PubMed     Abstract available

  19. WESTHOFF TH, Seibert FS, Anft M, Blazquez-Navarro A, et al
    A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral non-response.
    Kidney Int. 2021 Sep 9. pii: S0085-2538(21)00850.

  20. TAN XZ
    Fractured hemodialysis catheter in the right heart.
    Kidney Int. 2021;100:714.

    August 2021
  21. BOONGIRD S, Chuengsaman P, Phanprasert S, Kitpermkiat R, et al
    Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody to An Inactivated Whole-virus SARS-CoV-2 Vaccination in End-stage Kidney Disease Patients: An Initial Report.
    Kidney Int. 2021 Aug 19. pii: S0085-2538(21)00758.

  22. ZOCCALI C, Torino C, Mallamaci F, Sarafidis P, et al
    A randomized multicenter trial on a lung ultrasound guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk.
    Kidney Int. 2021 Aug 18. pii: S0085-2538(21)00748.
    PubMed     Abstract available

  23. VILAR E, Kaja Kamal RM, Fotheringham J, Busby A, et al
    A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function.
    Kidney Int. 2021 Aug 18. pii: S0085-2538(21)00749.
    PubMed     Abstract available

  24. FUNG WWS, Chow KM, Szeto CC
    Bilious peritoneal dialysate in a peritoneal dialysis patient.
    Kidney Int. 2021;100:485.

  25. KUMARESAN M, Matthew M, Parthasarathy R, Abraham G, et al
    Peritoneal calcification in a patient on peritoneal dialysis.
    Kidney Int. 2021;100:484.

  26. ROY-CHAUDHURY P, Saad TF, Trerotola S
    Drug-coated balloons and dialysis vascular access: is there light at the end of the tunnel . . .
    Kidney Int. 2021;100:278-280.
    PubMed     Abstract available

    July 2021
  27. PARK S, Lee S, Kim Y, Cho S, et al
    A Mendelian randomization study found causal linkage between telomere attrition and chronic kidney disease.
    Kidney Int. 2021 Jul 30. pii: S0085-2538(21)00730.
    PubMed     Abstract available

  28. MEHTA R, Cho ME, Cai X, Lee J, et al
    Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.
    Kidney Int. 2021 Jul 30. pii: S0085-2538(21)00731.
    PubMed     Abstract available

  29. IKIZLER TA, Himmelfarb J
    Chronic Kidney Disease Rescuing kidney patients from early demise: Role of anti-cytokine therapies.
    Kidney Int. 2021 Jul 21. pii: S0085-2538(21)00691.

  30. ESPI M, Charmetant X, Barba T, Koppe L, et al
    The ROMANOV study found impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis.
    Kidney Int. 2021 Jul 17. pii: S0085-2538(21)00679.
    PubMed     Abstract available

  31. BLAZQUEZ-NAVARRO A, Safi L, Meister TL, Thieme CJ, et al
    Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2 vaccinated dialysis patients.
    Kidney Int. 2021 Jul 14. pii: S0085-2538(21)00680.

  32. KAISER RA, Haller MC, Apfalter P, Kerschner H, et al
    Comparison of BNT162b2 (BioNTech/Pfizer) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients.
    Kidney Int. 2021 Jul 13. pii: S0085-2538(21)00678.

  33. SPEER C, Benning L, Tollner M, Nusshag C, et al
    Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.
    Kidney Int. 2021 Jul 12. pii: S0085-2538(21)00676.

    Reasons for COVID-19 vaccination hesitancy in hemodialysis patients.
    Kidney Int. 2021 Jul 10. pii: S0085-2538(21)00677.

  35. LAMEIRE N, Levin A, Kellum JA, Cheung M, et al
    Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
    Kidney Int. 2021 Jul 9. pii: S0085-2538(21)00662.
    PubMed     Abstract available

  36. MUREA M, Grey CR, Lok CE
    Shared-decision making in hemodialysis vascular access practice.
    Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00668.
    PubMed     Abstract available

  37. MANSOUR FA, Habib PK, El Haddad BN, Joubran NI, et al
    The Case | Bilateral submandibular swelling in a dialysis patient.
    Kidney Int. 2021;100:251-252.

  38. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    PubMed     Abstract available

    June 2021
  39. DUCLOUX D, Colladant M, Chabannes M, Yannaraki M, et al
    Humoral response after three doses of BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.
    Kidney Int. 2021 Jun 30. pii: S0085-2538(21)00655.

  40. MEHROTRA R, Stanaway IB, Jarvik GP, Lambie M, et al
    A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis.
    Kidney Int. 2021 Jun 28. pii: S0085-2538(21)00602.
    PubMed     Abstract available

  41. HAARHAUS M, Evenepoel P
    Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment.
    Kidney Int. 2021 Jun 5. pii: S0085-2538(21)00567.
    PubMed     Abstract available

  42. LUGTHART G, Jordans CCE, de Pagter APJ, Bresters D, et al
    Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
    Kidney Int. 2021 Jun 5. pii: S0085-2538(21)00579.
    PubMed     Abstract available

  43. FOLEY ED, Lombardi R, Patel V
    Hydroxycobalamin-induced pigmented effluent during dialysis.
    Kidney Int. 2021;99:1503.

  44. CHOWDHURY R, Jhamb M
    Intradialytic exercise improves left ventricular mass in hemodialysis patients.
    Kidney Int. 2021;99:1272-1274.
    PubMed     Abstract available

  45. STEVENS JS, Salazar-Schicchi J, Radhakrishnan J, Mohan S, et al
    The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy.
    Kidney Int. 2021;99:1507-1508.

  46. HENAUT L, Massy ZA
    Phosphate meeting cholesterol-consequences for cardiovascular disease in chronic kidney disease?
    Kidney Int. 2021;99:1264-1267.
    PubMed     Abstract available

  47. SOHN P, Narasaki Y, Rhee CM
    Intradialytic hypotension: is timing everything?
    Kidney Int. 2021;99:1269-1272.
    PubMed     Abstract available

    May 2021
  48. RODRIGUEZ-ESPINOSA D, Broseta JJ, Maduell F, Bedini JL, et al
    Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients.
    Kidney Int. 2021 May 31. pii: S0085-2538(21)00558.

  49. JOHANSEN KL, Garimella PS, Hicks CW, Kalra PA, et al
    Central and Peripheral Arterial Diseases in Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2021 May 4. pii: S0085-2538(21)00472.
    PubMed     Abstract available

  50. GLEESON S, Martin P, Bedi R, Lynch K, et al
    Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program.
    Kidney Int. 2021;99:1238-1239.

  51. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
    Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
    Kidney Int. 2021;99:1245.

  52. DRUEKE TB, Floege J
    Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?
    Kidney Int. 2021;99:1070-1072.
    PubMed     Abstract available

    April 2021
  53. LAMBOURG E, Colvin L, Guthrie G, Murugan K, et al
    The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00458.
    PubMed     Abstract available

  54. CHEN W, Caplin N, El Shamy O, Sharma S, et al
    Use of Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic in New York City: A multicenter observational study.
    Kidney Int. 2021 Apr 27. pii: S0085-2538(21)00456.
    PubMed     Abstract available

  55. BILLANY RE, Selvaskandan H, Adenwalla SF, Hull KL, et al
    Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.
    Kidney Int. 2021 Apr 20. pii: S0085-2538(21)00392.

  56. TORREGGIANI M, Blanchi S, Fois A, Fessi H, et al
    Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA Covid-19 vaccine. The war is far from being won.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00395.

  57. ANFT M, Blazquez-Navarro A, Paniskaki K, Skrzypczyk S, et al
    SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00394.

  58. YANAY NB, Freiman S, Shapira M, Wishahi S, et al
    Experience with SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00390.

  59. ATTIAS P, Sakhi H, Rieu P, Soorkia A, et al
    Antibody response to BNT162b2 vaccine in maintenance hemodialysis patients.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00393.

  60. PEEPLES J, Byku M, Hinderliter AL, Smith SV, et al
    Sparkling myocardium in a hemodialysis patient.
    Kidney Int. 2021;99:1028.

  61. GITOMER B, Pereira R, Salusky IB, Stoneback JW, et al
    Mineral bone disease in autosomal dominant polycystic kidney disease.
    Kidney Int. 2021;99:977-985.
    PubMed     Abstract available

    March 2021
  62. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    PubMed     Abstract available

  63. CLARKE CL, Prendecki M, Dhutia A, Gan J, et al
    Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
    Kidney Int. 2021 Mar 24. pii: S0085-2538(21)00295.
    PubMed     Abstract available

  64. D'AGATA EMC, Apata IW, Booth S, Boyce JM, et al
    Kidney Int. 2021 Mar 2. pii: S0085-2538(21)00270.
    PubMed     Abstract available

  65. FOTI KE, Wang D, Chang AR, Selvin E, et al
    Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Kidney Int. 2021;99:686-695.
    PubMed     Abstract available

  66. CHEUNG AK, Chang TI, Cushman WC, Furth SL, et al
    Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
    Kidney Int. 2021;99:559-569.
    PubMed     Abstract available

  67. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
    Kidney Int. 2021;99.

  68. DUCLOUX D, Rebibou JM, Courivaud C
    Pretransplant coronary artery disease screening is still valid.
    Kidney Int. 2021;99:772.

  69. EVANS RDR, Smyth B, Levin A, Jha V, et al
    The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals.
    Kidney Int. 2021;99:551-554.

    February 2021
  70. OBJOIS T, Mary A, Brazier M, Bennis Y, et al
    Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification.
    Kidney Int. 2021 Feb 26. pii: S0085-2538(21)00212.
    PubMed     Abstract available

  71. ZHOU C, He Q, Gan H, Zeng T, et al
    Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans.
    Kidney Int. 2021 Feb 22. pii: S0085-2538(21)00188.
    PubMed     Abstract available

  72. KEANE DF, Raimann JG, Zhang H, Willetts J, et al
    The time of onset of intradialytic hypotension during a hemodialysis session associates with clinical parameters and mortality.
    Kidney Int. 2021 Feb 16. pii: S0085-2538(21)00190.
    PubMed     Abstract available

  73. FRANCIS A, Baigent C, Ikizler TA, Cockwell P, et al
    The urgent need to vaccinate dialysis patients against SARS-CoV-2: A call to action.
    Kidney Int. 2021 Feb 11. pii: S0085-2538(21)00177.

  74. CANAS JJ, Starr MC, Hooks J, Arregui S, et al
    Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.
    Kidney Int. 2021;99:484-486.

  75. MAJOR RW, Burton JO
    "To take or not to take an aspirin?" The age-old question of cardiovascular disease primary prevention for people with chronic kidney disease.
    Kidney Int. 2021;99:308-310.
    PubMed     Abstract available

  76. RANKIN AJ, Mark PB
    Cardiac screening prior to renal transplantation-good intentions, rather than good evidence, dictate practice.
    Kidney Int. 2021;99:306-308.
    PubMed     Abstract available

    January 2021
  77. TORREGGIANI M, Ebikili B, Blanchi S, Piccoli GB, et al
    Two episodes of SARS-CoV-2 infection in a patient on chronic hemodialysis. A note of caution.
    Kidney Int. 2021 Jan 21. pii: S0085-2538(21)00067.

  78. THAUNAT O, Legeai C, Bastien O, Caillard S, et al
    Response to "On the need to better protect hemodialysis patients. A comment on the IMPORTANT study": one more IMPORTANT thing!
    Kidney Int. 2021 Jan 10. pii: S0085-2538(20)31527.

  79. MASSIMO T, Hafedh F, Barbara PG
    On the need to better protect hemodialysis patients. A comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".
    Kidney Int. 2021 Jan 9. pii: S0085-2538(20)31525.

  80. URSEM SR, Heijboer AC, D'Haese PC, Behets GJ, et al
    Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.
    Kidney Int. 2021 Jan 7. pii: S0085-2538(20)31549.
    PubMed     Abstract available

  81. VINSON AJ, Chong AS, Clegg D, Falk C, et al
    Kidney Int. 2021 Jan 4. pii: S0085-2538(20)31545.

    Equitable hemodialysis for undocumented immigrant patients: prioritizing patient voices in care implementation.
    Kidney Int. 2021;99:26-28.
    PubMed     Abstract available

  83. KLOMJIT N, Shah K, Herrmann SM, Lieske JC, et al
    The Case | An unusual cause of tender skin lesion in an end-stage kidney disease patient.
    Kidney Int. 2021;99:275-276.

  84. BADE N, Rizk DV
    The mystery of cherry red ultrafiltrate in continuous renal replacement therapy.
    Kidney Int. 2021;99:270.

  85. LARCHER R, Kuster N, Bargnoux AS, Klouche K, et al
    Discrepant post-filter ionized calcium concentrations by 2 common gas analyzers in continuous renal replacement therapy using regional citrate anticoagulation: another piece of the puzzle.
    Kidney Int. 2021;99:268-269.

  86. FLOEGE J, Johnson RJ
    Hyperuricemia and progression of chronic kidney disease: to treat or not to treat?
    Kidney Int. 2021;99:14-16.

  87. DINH A, McCulloch CE, Ku E
    Predicting long-term kidney allograft outcomes: pitfalls and progress.
    Kidney Int. 2021;99:24-26.
    PubMed     Abstract available

    December 2020
  88. JUNI RP, Al-Shama R, Kuster DWD, van der Velden J, et al
    Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction.
    Kidney Int. 2020 Dec 22. pii: S0085-2538(20)31532.
    PubMed     Abstract available

  89. STEL VS, de Jong RW, Kramer A, Andrusev AM, et al
    Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe.
    Kidney Int. 2020 Dec 21. pii: S0085-2538(20)31529.
    PubMed     Abstract available

  90. Y-H LIN H, Chen Y, Chen YH, Ta AP, et al
    Tubular mitochondrial AKT1 is activated during ischemia reperfusion injury and has a critical role in predisposition to chronic kidney disease.
    Kidney Int. 2020 Dec 11. pii: S0085-2538(20)31408.
    PubMed     Abstract available

  91. PIERCE CB, Munoz A, Ng DK, Warady BA, et al
    Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease.
    Kidney Int. 2020 Dec 7. pii: S0085-2538(20)31419.
    PubMed     Abstract available

  92. MARTIN DE, Parsons JA, Caskey FJ, Harris DCH, et al
    Ethics of kidney care in the era of COVID-19.
    Kidney Int. 2020;98:1424-1433.
    PubMed     Abstract available

    November 2020
  93. BARBOUR SJ, Coppo R, Er L, Russo ML, et al
    Updating the International IgA Nephropathy Prediction Tool for use in children.
    Kidney Int. 2020 Nov 18. pii: S0085-2538(20)31385.
    PubMed     Abstract available

  94. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.

  95. PALMER BF, Clegg DJ
    Gastrointestinal potassium binding in hemodialysis.
    Kidney Int. 2020;98:1095-1097.
    PubMed     Abstract available

  96. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.

  97. REN Q, Zhou Y, Chen G, Li X, et al
    Age-adapted definition of chronic kidney disease based on Chronic Kidney Disease Epidemiology Collaboration and full age spectrum equation.
    Kidney Int. 2020;98:1350-1352.

  98. HANNA RM, Rhee CM, Kalantar-Zadeh K
    Metformin in chronic kidney disease: a strong dose of caution.
    Kidney Int. 2020;98:1101-1105.

  99. DE BROE ME, Jouret F
    Does metformin do more benefit or harm in chronic kidney disease patients?
    Kidney Int. 2020;98:1098-1101.

    October 2020
  100. HILL GALLANT KM, Stremke ER, Trevino L, Moorthi RN, et al
    EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a Phase 1b randomized cross-over trial in hemodialysis patients.
    Kidney Int. 2020 Oct 30. pii: S0085-2538(20)31246.
    PubMed     Abstract available

  101. CERVANTES L, Tong A, Camacho C, Collings A, et al
    Patient-reported outcomes and experiences in the transition of undocumented patients from emergency to scheduled hemodialysis.
    Kidney Int. 2020 Oct 27. pii: S0085-2538(20)30936.
    PubMed     Abstract available

  102. SHLIPAK MG, Tummalapalli SL, Boulware LE, Grams ME, et al
    The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2020 Oct 22. pii: S0085-2538(20)31210.
    PubMed     Abstract available

  103. HSU CM, Weiner DE
    COVID-19 in Dialysis Patients: Outlasting and Outsmarting a Pandemic.
    Kidney Int. 2020 Oct 13. pii: S0085-2538(20)31203.
    PubMed     Abstract available

  104. TAKESHITA A, Yasuma T, Nishihama K, D'Alessandro-Gabazza CN, et al
    Thrombomodulin ameliorates transforming growth factor-beta1-mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway.
    Kidney Int. 2020 Oct 8. pii: S0085-2538(20)30688.
    PubMed     Abstract available

  105. FLOEGE J, Drueke TB
    Mineral and bone disorder in chronic kidney disease: pioneering studies.
    Kidney Int. 2020;98:807-811.

  106. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
    Kidney Int. 2020;98.

    September 2020
  107. JAGER KJ, Kramer A, Chesnaye NC, Couchoud C, et al
    Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
    Kidney Int. 2020 Sep 23. pii: S0085-2538(20)31081.
    PubMed     Abstract available

    August 2020
  108. BONTHUIS M, Cuperus L, Chesnaye NC, Akman S, et al
    Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe.
    Kidney Int. 2020;98:464-475.
    PubMed     Abstract available

    August 2019
  109. MALVAR A, Alberton V, Lococo B, Ferrari M, et al
    Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.
    Kidney Int. 2019 Aug 20. pii: S0085-2538(19)30816.
    PubMed     Abstract available

  110. DUPONT V, Colosio C, Hureaux M, Mokri L, et al
    The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient.
    Kidney Int. 2019;96:529-530.

    June 2019
  111. RANGASWAMI J, Bangalore S, Kaplan B, Birdwell KA, et al
    Cardiovascular disease care fragmentation in kidney transplantation: a call for action.
    Kidney Int. 2019 Jun 10. pii: S0085-2538(19)30586.

    May 2019
  112. DRIOLLET B, Bayer F, Chatelet V, Macher MA, et al
    Social deprivation is associated with poor kidney transplantation outcome in children.
    Kidney Int. 2019 May 28. pii: S0085-2538(19)30530.
    PubMed     Abstract available

    April 2019
  113. NASR SH, Fogo AB
    New developments in the diagnosis of fibrillary glomerulonephritis.
    Kidney Int. 2019 Apr 9. pii: S0085-2538(19)30407.
    PubMed     Abstract available

  114. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Abstract available

    March 2019
  115. EVENEPOEL P, Claes K, Meijers B, Laurent MR, et al
    Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30105.
    PubMed     Abstract available

    February 2019
  116. FRIBOURG M, Anderson L, Fischman C, Cantarelli C, et al
    T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30192.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.